
Mega Doctor News
Medical News Today
A recent study published in JAMA on November 9, investigates a drug called enlicitide.
The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol.
For these individuals, lifestyle changes and statins are often inadequate to bring their levels of LDL cholesterol down.
Follow the link below to Medical News Today to read the full story:
Information source: https://www.medicalnewstoday.com











